246
Views
3
CrossRef citations to date
0
Altmetric
Larynx

EGFR cut-off point for prognostic impact in laryngeal squamous cell carcinoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 603-607 | Received 31 Dec 2019, Accepted 29 Feb 2020, Published online: 18 Mar 2020

References

  • Wieduwilt MJ, Moasser MM. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci. 2008;65(10):1566–1584.
  • Almadori G, Cadoni G, Galli J, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer. 1999;84(2):188–191.
  • Maurizi M, Almadori G, Ferrandina G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer. 1996;74(8):1253–1257.
  • Avilés-Salas A, Muñiz-Hernández S, Maldonado-Martínez H, et al. Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer. Oncol Lett. 2017;13(2):912–920.
  • Furuta Y, Takasu T, Asai T, et al. Clinical significance of the epidermal growth factor receptor gene in m squamous cell carcinomas of the nasal cavities and paranasal sinuses. Cancer. 1992;69(2):358–362.
  • Maiorano E, Favia G, Maisonneuve P, et al. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol. 1998;185(2):167–174.
  • Keren S, Shoude Z, Lu Z, et al. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Tumor Biol. 2014;35(3):2285–2295.
  • Hiraishi Y, Wada T, Nakatani K, et al. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res. 2006;12(2):87–91.
  • Kontić M, Milovanović J, Čolović Z, et al. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2015;272(2):401–405.
  • Rüschoff J, Kerr K, Grote H, et al. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test. Arch Pathol Lab Med. 2013;137(9):1255–1261.
  • Pirker R, Pereira J, von Pawel J, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol. 2012;13(1):33–42.
  • Kimura I, Kitahara H, Ooi K, et al. Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition. Oncol Lett. 2016;11(1):201–207.
  • Smith BD, Smith GL, Carter D, et al. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(7):780–785.
  • Mayer A, Zahnreich S, Brieger J, et al. Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck. Br J Cancer. 2016;115(11):1351–1358.
  • Polanska H, Raudenska M, Hudcová K, et al. Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients. Oncol Lett. 2016;12(3):2127–2132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.